Search results for "disease control"

showing 10 items of 116 documents

The Immunology of Zoonotic Infections

2012

Zoonotic infections are in general defined as infections transmitted from animal to man (and less frequently vice versa), either directly (through contact or contact with animal products) or indirectly (through an intermediate vector as an arthropod or an insect) [1]. Although the burden of zoonotic infections worldwide is major, both in terms of immediate and long-term morbidity and mortality [2, 3] and in terms of emergence/reemergence and socioeconomical, ecological, and political correlations [4], scientific and public health interest and funding for these diseases remain relatively minor. Zoonoses include diseases induced by diverse pathogens (bacteria, viruses, fungi, and parasites), …

lcsh:Immunologic diseases. AllergyArticle SubjectEcology (disciplines)ImmunologyDiseaseBiologymedicine.disease_causeCommunicable DiseasesZoonosesPandemicmedicineAnimalsHumansImmunology and AllergySmallpoxZoonotic InfectionZoonosisimmunology; zoonosisCommunicable Disease Control ZoonosesGeneral Medicinezoonosismedicine.diseaseInfluenza A virus subtype H5N1EditorialVector (epidemiology)Communicable Disease ControlImmunologylcsh:RC581-607Clinical and Developmental Immunology
researchProduct

Adherence to biological therapy in dermatological patients during the COVID‐19 pandemic in Western Sicily

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySkin DiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19DermatologySkin DiseasesVirologyMedication AdherenceBiological TherapyCommunicable Disease ControlEpidemiologyPandemicmedicineHumansbusinessSicilyHumanInternational Journal of Dermatology
researchProduct

Recommendations for ophthalmologic practice during the easing of COVID‐19 control measures

2021

Abstract In the context of the COVID‐19 pandemic, this paper provides recommendations for medical eye care during the easing of control measures after lockdown. The guidelines presented are based on a literature review and consensus among all Spanish Ophthalmology Societies regarding protection measures recommended for the ophthalmologic care of patients with or without confirmed COVID‐19 in outpatient, inpatient, emergency and surgery settings. We recommend that all measures be adapted to the circumstances and availability of personal protective equipment at each centre and also highlight the need to periodically update recommendations as we may need to readopt more restrictive measures de…

medicine.medical_specialtyConsensusEye DiseasesCoronavirus disease 2019 (COVID-19)Control (management)Context (language use)Review ArticleEnfermedades infecciosasEye careeye care03 medical and health sciencesCOVID-19 eye care eye health lockdown easing pandemic personal protective equipment0302 clinical medicineCOVID‐19eye healthSalud públicaEpidemiologyPandemicHealth caremedicineHumansPandemicsReview ArticlesPersonal protective equipmentSARS-CoV-2business.industrypandemicCOVID-19General Medicinemedicine.diseaseTelemedicineVirusOphthalmologyAtenció primàriaSpainCommunicable Disease ControlPractice Guidelines as Topiclockdown easingpersonal protective equipment030221 ophthalmology & optometryUlls Malalties i defectesOftalmologíaMedical emergencybusinessUlls030217 neurology & neurosurgery
researchProduct

Home-Based Resistance Training for Older Subjects during the COVID-19 Outbreak in Italy: Preliminary Results of a Six-Months RCT.

2020

Background. The aim of this study was to evaluate the effect of a six-month home-based resistance-training program on muscle health and physical performance in healthy older subjects during the unique condition of home confinement caused by the COVID-19 pandemic. Methods. This was a randomized-controlled study that enrolled older participants that were allocated to either an experimental group performing the six-months exercise prescription (EXE) or a control group (CON). At the beginning (PRE), and after 6 months (POST), participants were assessed for muscle strength, balance, gait assessment and body composition by dual energy X-ray absorptiometry and magnetic resonance imaging. Normality…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Health Toxicology and Mutagenesislcsh:MedicineArticlelaw.inventionsarcopenia03 medical and health sciences0302 clinical medicinerisk of fallRandomized controlled triallawInternal medicineEpidemiologymedicineHumansmagnetic resonance imaging030212 general & internal medicineMuscle StrengthPandemicsBalance (ability)AgedAged 80 and overDXAexercisebusiness.industrylcsh:RagingPublic Health Environmental and Occupational HealthOutbreakCOVID-19Resistance TrainingMiddle Agedmedicine.diseaseItalySarcopeniaGait analysisCommunicable Disease ControlBody CompositionbusinessExercise prescription030217 neurology & neurosurgeryInternational journal of environmental research and public health
researchProduct

Chronic Pain and COVID-19: pathophysiological, clinical and organizational issues

2020

During the lockdown phase of the COVID-19 pandemic, a call not to neglect the continuum of care of patients who present with chronic diseases, including pain, was made. In the field of pain, COVID-19 had an impact both from a clinical (i.e., the influence of SARS-CoV-2 infection on pain) and organizational (i.e., how patients with chronic pain should be managed in the post-COVID-19 era) perspective. Furthermore, patients with chronic pain are also frequently frail subjects, affected from multiple comorbidities and hence are at increased risk of infection. On these bases, how the necessity to continue pain therapy will be pursued in the post-COVID-19 era? In this paper, we comment on the abo…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectMEDLINEChronic painCOVID-19Chronic painmedicine.diseaseNeglectAnesthesiology and Pain MedicineIncreased riskPandemicCommunicable Disease ControlMedicineHumansbusinessIntensive care medicinePandemicsmedia_commonPain therapy
researchProduct

WHO needs high FIO2?

2017

World Health Organization and the United States Center for Disease Control have recently recommended the use of 0.8 FIO2 in all adult surgical patients undergoing general anaesthesia, to prevent surgical site infections. This recommendation has arisen several discussions: As a matter of fact, there are numerous studies with different results about the effect of FIO2 on surgical site infection. Moreover, the clinical effects of FIO2 are not limited to infection control. We asked some prominent authors about their comments regarding the recent recommendations.

medicine.medical_specialtyEmergency Medicine; Anesthesiology and Pain Medicine10216 Institute of Anesthesiologybusiness.industryMEDLINE610 Medicine & health030208 emergency & critical care medicineDisease controlWorld health3. Good health03 medical and health sciences0302 clinical medicineAnesthesiology and Pain Medicine030202 anesthesiologySurgical sitemedicineEmergency MedicineInfection controlGeneral anaesthesia2703 Anesthesiology and Pain Medicine2711 Emergency MedicineIntensive care medicinebusinessSurgical site infectionSurgical patients
researchProduct

Disposal Behavior of Used Masks during the COVID-19 Pandemic in the Moroccan Community: Potential Environmental Impact.

2021

The spread of coronavirus disease-2019 (COVID-19) levied on the Moroccan authorities to increase their mask production capacity, which reached up to 12 million facemask units produced per day. This increase in personal protective equipment (PPE) production and consumption is an efficient tool to address the spread of COVID-19. However, this results in more plastic and microplastic debris being added into the land and marine environments, which will harm the ecosystem, wildlife, and public health. Such a situation needs deep individual behavior observation and tracking, as well as an assessment of the potential environmental impact of this new type of waste. For this reason, we assessed the …

medicine.medical_specialtyHealth Toxicology and MutagenesisPopulation010501 environmental sciences01 natural sciencesFacemasksenvironmental impactArticleEnvironmental impact03 medical and health sciencesplastic pollution0302 clinical medicineCOVID‐19Environmental healthmedicineHumansEnvironmental impact assessment030212 general & internal medicineeducationPersonal protective equipmentPandemicsPersonal Protective EquipmentEcosystem0105 earth and related environmental sciencesConsumption (economics)education.field_of_studyBehaviorPublic healthbehaviorSARS-CoV-2Public healthpublic healthPublic Health Environmental and Occupational HealthRMasksCOVID-19MoroccoHarmGeographyGreenhouse gasPlastic pollutionCommunicable Disease ControlfacemasksMedicinePlastic pollutionPlasticsInternational journal of environmental research and public health
researchProduct

Epidemiology and management of foodborne nematodiasis in the European Union, systematic review 2000–2016

2018

Background: Foodborne nematodiasis are caused by the ingestion of food contaminated by helminths. In Europe, these diseases are present in all countries. Objectives: To review the available data on epidemiology and management of foodborne nematodiasis in the European Union, detect any trends and determine the possible causes of the observed changes. Methods: A review of available literature published between 2000 and 2016 was conducted. Results: Out of 1523 cases described in the literature, 1493 cases were autochthonous and 30 cases were imported. The detected parasites were Toxocara spp (34.7%), Ascaris lumbricoides (27.1%), Trichinella spp (21.9%), Anisakis spp (15.5%) and Angiostrongylu…

medicine.medical_specialtyNematodaFood HandlingReviewsMicrobiologyFood handlingFoodborne Diseases03 medical and health sciences0302 clinical medicineEnvironmental healthparasitic diseasesEpidemiologymedicineAnimalsHumansHelminthsmedia_common.cataloged_instance030212 general & internal medicineEuropean unionNematode Infectionsmedia_commondigestive oral and skin physiologyZoonosisPublic Health Environmental and Occupational HealthGeneral Medicinemedicine.diseaseEuropeInfectious DiseasesGeographyCommunicable Disease Control030211 gastroenterology & hepatologyParasitologyPathogens and Global Health
researchProduct

Are we really seeing the total costs of surgical site infections? A Spanish study.

2007

To identify overall costs generated by surgical site infections (SSI) patients, including indirect costs. A prospective study of case series of patients who have undergone major surgical treatment was undertaken. Patients who suffered SSI were compared with controls (nested case-control design). Centers for Disease Control and Prevention definitions were followed and SSI established. Overall costs and indirect related morbidity/mortality costs were estimated. The study was performed in a general, tertiary hospital (Valencia, Spain) for 4.5 years. Surgical site infections patients were 9.02% of the total people who underwent surgery. Their stays were prolonging by 14 days, and resources were…

medicine.medical_specialtyTotal costbusiness.industryDermatologyLength of Staymedicine.diseaseDisease controlIndirect costsCost of IllnessSpainEmergency medicineHealth careSurgical siteCost of illnessmedicineHumansSurgical Wound InfectionSurgeryMedical emergencyHospital CostsbusinessSurgical treatmentProspective cohort studyhealth care economics and organizationsWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
researchProduct

Disease control and treatment pathways of asthma patients after initiating ICS/LABA

2019

Introduction: GINA guidelines recommend medium dose (MED) and high dose (HD) ICS/LABA as the preferred controller for step 4 asthma patients and clinicians should consider step up/down based on their patients’ asthma control. Limited data is available on how step 4 patients respond to ICS/LABA and how they step up/down in clinical practice. Methods: We conducted a retrospective cohort study using UK Clinical Practice Research Datalink to assess control status of asthma patients in one year after initiating a MED or HD ICS/LABA between 2007 and 2015, and examined their treatment pathways within one year after the treatment initiation. Results: 29,229 and 16, 575 patients initiated MED and HD…

medicine.medical_specialtybiologyExacerbationbusiness.industryOffice visitsRetrospective cohort studyLamamedicine.diseasebiology.organism_classificationDisease controlMedication possession ratioInternal medicineIcs labamedicinebusinesshormones hormone substitutes and hormone antagonistsAsthmaAirway pharmacology and treatment
researchProduct